Literature DB >> 15087307

Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.

Nirupa R Matthan1, Francine K Welty, P Hugh R Barrett, Carrie Harausz, Gregory G Dolnikowski, John S Parks, Robert H Eckel, Ernst J Schaefer, Alice H Lichtenstein.   

Abstract

OBJECTIVE: To determine mechanisms contributing to decreased high-density lipoprotein cholesterol (HDL-C) and increased low-density lipoprotein cholesterol (LDL-C) concentrations associated with hydrogenated fat intake, kinetic studies of apoA-I, apoB-100, and apoB-48 were conducted using stable isotopes. METHODS AND
RESULTS: Eight postmenopausal hypercholesterolemic women were provided in random order with 3 diets for 5-week periods. Two-thirds of the fat was soybean oil (unsaturated fat), stick margarine (hydrogenated fat), or butter (saturated fat). Total and LDL-C levels were highest after the saturated diet (P<0.05; saturated versus unsaturated) whereas HDL-C levels were lowest after the hydrogenated diet (P<0.05; hydrogenated versus saturated). Plasma apoA-I levels and pool size (PS) were lower, whereas apoA-I fractional catabolic rate (FCR) was higher after the hydrogenated relative to the saturated diet (P<0.05). LDL apoB-100 levels and PS were significantly higher, whereas LDL apoB-100 FCR was lower with the saturated and hydrogenated relative to the unsaturated diet. There was no significant difference among diets in apoA-I or B-100 production rates or apoB-48 kinetic parameters. HDL-C concentrations were negatively associated with apoA-I FCR (r=-0.56, P=0.03) and LDL-C concentrations were negatively correlated with LDL apoB-100 FCR (r=-0.48, P=0.05).
CONCLUSIONS: The mechanism for the adverse lipoprotein profile observed with hydrogenated fat intake is determined in part by increased apoA-I and decreased LDL apoB-100 catabolism.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087307     DOI: 10.1161/01.ATV.0000128410.23161.be

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

Review 1.  Diet and low-density lipoprotein particle size.

Authors:  Sophie Desroches; Benoît Lamarche
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

Review 2.  Dietary trans fatty acids: review of recent human studies and food industry responses.

Authors:  J Edward Hunter
Journal:  Lipids       Date:  2006-11       Impact factor: 1.880

Review 3.  Low-density lipoprotein cholesterol, apolipoprotein B, and risk of coronary heart disease: from familial hyperlipidemia to genomics.

Authors:  Christopher C Imes; Melissa A Austin
Journal:  Biol Res Nurs       Date:  2012-04-23       Impact factor: 2.522

Review 4.  Effect of very high-fat diets on body weight, lipoproteins, and glycemic status in the obese.

Authors:  Frederick F Samaha
Journal:  Curr Atheroscler Rep       Date:  2005-11       Impact factor: 5.113

Review 5.  Current Evidence Supporting the Link Between Dietary Fatty Acids and Cardiovascular Disease.

Authors:  Shatha Hammad; Shuaihua Pu; Peter J Jones
Journal:  Lipids       Date:  2015-12-30       Impact factor: 1.880

Review 6.  Dietary trans fatty acids and cardiovascular disease risk: past and present.

Authors:  Alice H Lichtenstein
Journal:  Curr Atheroscler Rep       Date:  2014-08       Impact factor: 5.113

7.  Plasma concentrations of trans fatty acids in persons with type 2 diabetes between September 2002 and April 2004.

Authors:  Dawn C Schwenke; John P Foreyt; Edgar R Miller; Rebecca S Reeves; Mara Z Vitolins
Journal:  Am J Clin Nutr       Date:  2013-02-27       Impact factor: 7.045

Review 8.  Differential effects of adulterated versus unadulterated forms of linoleic acid on cardiovascular health.

Authors:  Stephen D Anton; Kacey Heekin; Carrah Simkins; Andres Acosta
Journal:  J Integr Med       Date:  2013-01

9.  Gender-specific differences in the kinetics of nonfasting TRL, IDL, and LDL apolipoprotein B-100 in men and premenopausal women.

Authors:  Nirupa R Matthan; Susan M Jalbert; P Hugh R Barrett; Gregory G Dolnikowski; Ernst J Schaefer; Alice H Lichtenstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

10.  Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes.

Authors:  Bruno Vergès; Emmanuel Florentin; Sabine Baillot-Rudoni; Jean-Michel Petit; Marie Claude Brindisi; Jean-Paul Pais de Barros; Laurent Lagrost; Philippe Gambert; Laurence Duvillard
Journal:  J Lipid Res       Date:  2009-01-22       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.